William Price News
-
California’s $20 billion wine industry needs to work harder to entice young consumers who resist conventional marketing, said William Price, a co-founder of buyout firm TPG Capital and chairman of Vincraft Group.
-
On a warm October afternoon, a steel- framed concrete warehouse north of San Francisco is inundated with grapes. Forklifts bearing fruit from the nearby Russian River Valley deliver their loads to a slow-moving conveyor belt. Flanking both sides, winemaking interns pick out stems and sunburned grapes as they groove to hip-hop music thumping from loudspeakers.
-
Rambus Inc.’s computer memory failed to become an industry standard because it was “dethroned” by Intel Corp., not as a result of collusion by rivals, a lawyer for Micron Technology Inc. told a jury.
-
Bank of America Corp. will pay a record $335 million to compensate Countrywide Financial Corp. borrowers who were charged more for home loans based on race and national origin.
-
An ex-Galleon Group LLC trader and expert-networking consultant were sentenced yesterday to 10 years and four years in prison for their roles in a nationwide insider-trading scandal, just three weeks before Raj Rajaratnam, the man at the center of the investigation, is to learn his fate.
-
A witness for Apple Inc. told a jury that a “substantial portion” of consumers that he surveyed confuse Samsung Electronics Co.’s tablet computers and smartphones with Apple products.
-
Four men arrested last month for allegedly participating in a “criminal club” that made almost $62 million using illegal tips to trade in Dell Inc. stock pleaded not guilty.
-
Samsung Electronics Co. would owe Apple Inc. $2.5 billion to $2.75 billion in damages for infringing the iPhone maker’s intellectual property, a witness said at the U.S. jury trial between the companies.
-
Samsung Electronics Co.’s request to stay a court order barring sales of its Galaxy Nexus smartphone in the U.S. will be ruled on “shortly,” a federal judge said today at a court hearing in San Jose, California.
-
Johnson & Johnson may have trouble proving to some investors that the time is right for a big acquisition as it seeks to recover from pulling more than 50 drugs and devices off the market since the start of 2010.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page